首页|BREAKING BARRIERS TO BIOTECH TRANSLATION IN CHINA
BREAKING BARRIERS TO BIOTECH TRANSLATION IN CHINA
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
In recent years a string of important and innovative cancer drugs developed by Chinese companies have been approved by the US Food and Drug Administration (FDA). The approvals provided immediate access to the world's largest and most profitable pharmaceutical market, and boosted the credibility and value of Chinese companies behind the new therapies. These drugs also marked a turning point for China's industry which has stepped up its biotechnology R&D efforts, according to a new Chinese-language report, The Blue Book on the Translation of China's Biotechnology Achievements.
NETL
NSTL
